| Pharmaceutical active ingredients: |
| Phenylbutazone |
| Available forms, composition and doses of Butapirazol: |
| Suppositories; Rectal; Phenylbutazone 250 mg |
| Butapirazol medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AA01 - PhenylbutazoneM02AA01 - Phenylbutazone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Butanil | Terbutaline Sulfate | Raza Manufacturing; Pharmaniaga |
| Butanimide | Succinimide | Unidentified Pharmaceutical Company |
| Butapap | Acetaminophen; Butalbital | Mikart Pharmaceuticals |
| Butaparin | Heparin Sodium; Phenylbutazone; Thymol | G. Streuli |
| Butaphen | Phenylbutazone | Unidentified Pharmaceutical Company |
| Butapirazole | Phenylbutazone | GlaxoSmithKline |
| Butapirin | Acetaminophen; Phenylbutazone Calcium | Instituto de Quimica e Biologia |
| Butaproxyvon | Acetaminophen; Diclofenac Sodium | Wockhardt |
| Buta-Proxyvon Capsules | Acetaminophen; Dextropropoxyphene Hydrochloride; Diclofenac Sodium | Wockhardt |
| Buta-Proxyvon Gel | Diclofenac Diethylamine; Linseed Oil; Menthol; Methyl Salicylate | Wockhardt |